Daxor Corporation (DXR)

개요 뉴스 가격 이력 토론 예측 배당 이력

Relative Volume:

Daxor Corporation Stock (DXR) Company Profile

Daxor Corporation

Healthcare (1100)

212-330-8500

Empire State Building, Suite 7120 350 Fifth Avenue, New York, NY

최신 SEC 제출 서류

DXR's Discussions on Twitter

Compare DXR vs ISRG, BDX, MDLN, ALC, RMD

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
DXR Daxor Corporation	10.50	61.48M	503.40K	9.17M	-604.40K	1.8109
ISRG Intuitive Surgical Inc	426.39	153.29B	10.58B	3.00B	2.83B	8.2437
BDX Becton Dickinson Co	157.37	42.86B	21.37B	1.41B	3.07B	3.9437
MDLN Medline Inc	42.98	36.15B	29.14B	1.07B	1.05B	1.1956
ALC Alcon Inc	67.04	33.32B	10.63B	819.00M	1.59B	1.6577
RMD Resmed Inc	218.66	31.68B	5.54B	1.52B	1.74B	10.37

Daxor Corporation Stock (DXR) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2019-05-16	개시	Ascendiant Capital Markets	Buy

Daxor Corporation 주식(DXR)의 최신 뉴스

Daxor Corporation (DXR) 재무 분석

Daxor Corporation 주식 (DXR) 내부자 거래

내부자 거래	관계	날짜	거래	비용	#주식	가치 ($)	#주식 총계
Michel Robert J	Chief Financial Officer	Mar 31 '26	Buy	9.90	1,000	9,900	21,050

Daxor Corporation (DXR)

Daxor Corporation Stock (DXR) Company Profile

Compare DXR vs ISRG, BDX, MDLN, ALC, RMD

Daxor Corporation Stock (DXR) Upgrades & Downgrades

Daxor Corporation 주식(DXR)의 최신 뉴스

Daxor to exhibit blood volume analyzer at dysautonomia conference By Investing.com - Investing.com Canada

Daxor debuts Blood Volume Analyzer at dysautonomia conference - Stock Titan

DXRDaxor Corp Options - Finviz

Avoiding Lag: Real-Time Signals in (DXR) Movement - Stock Traders Daily

Daxor Corporation (DXR) Edges Higher, Testing Key Resistance ZoneAdvance Decline Volume - dars.gov.et

Enterprise value to EBITDA forward of Daxor Corporation – NASDAQ:DXR - TradingView

Price to sales forward of Daxor Corporation – FWB:DX5 - TradingView

Price to book forward of Daxor Corporation – FWB:DX5 - TradingView

Enterprise value to revenue forward of Daxor Corporation – NASDAQ:DXR - TradingView

Enterprise value to EBIT forward of Daxor Corporation – NASDAQ:DXR - TradingView

Price to earnings forward of Daxor Corporation – NASDAQ:DXR - TradingView

Enterprise value to EBITDA forward of Daxor Corporation – FWB:DX5 - TradingView

Daxor Corporation (DXR) Edges Lower, Testing Support Levels Near $10.25Market Profile - dars.gov.et

DX5 Forecast — Price Target — Prediction for 2027 - TradingView

Daxor Corporation Actuals & Estimates (NASDAQ:DXR) - TradingView

DXR Forecast — Price Target — Prediction for 2027 - TradingView

Form 4 Daxor Corp For: 25 June By Investing.com - Investing.com South Africa

Daxor (DXR) CFO receives 12,000-share stock grant, now holds 33,050 - Stock Titan

DAXOR (DXR) CEO receives 30,000-share equity grant, now holds 243,694 - Stock Titan

Daxor (DXR) Chief Scientific Officer receives 25,000-share stock grant - Stock Titan

Daxor (DXR) director granted 2,500 stock options at $10.14 - Stock Titan

Daxor (DXR) director awarded 2,500 stock options at $10.14 strike - Stock Titan

DAXOR CORP (DXR) director receives 2,500 stock options at $10.14 strike - Stock Titan

DAXOR (DXR) director awarded 2,500 stock options at $10.14 strike price - Stock Titan

Daxor Shareholders Reelect Board and Ratify Auditor - The Globe and Mail

Daxor Corporation 8-K Filing June 2026: Shareholder Vote Results, Nasdaq Listing, and Company Details - Minichart

Daxor (NASDAQ: DXR) investors reelect full board and ratify Bush & Associates as auditor - Stock Titan

Number of shareholders of Daxor Corporation – BOATS:DXR - TradingView

Daxor Corporation (DXR) Holds Near Support After Modest DeclineAdaptive Moving Average - dars.gov.et

Discipline and Rules-Based Execution in DXR Response - Stock Traders Daily

Daxor (DXR) Proxy Filing Summary - Quartr

Daxor (DXR) Q4 2025 earnings summary - Quartr

Daxor (DXR) Q2 2024 earnings summary - Quartr

Daxor (DXR) Corporate Presentation Summary - Quartr

Daxor (DXR) Q4 2024 earnings summary - Quartr

Daxor Corp (DXR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Daxor Corp (DXR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Daxor Corp (DXR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Daxor Corp (DXR) Institutional Confidence - TradingKey

Daxor Corp (DXR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Daxor Corp (DXR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Daxor Corp (DXR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Daxor Corp (DXR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Daxor Corp (DXR) Valuation: PE, PB & Fair Value Analysis - TradingKey

Behavioral Patterns of DXR and Institutional Flows - Stock Traders Daily

Daxor Corporation (DXR) Declines 4.39%: Approaching Key Support Near $10.07PCR Moving Average - newsline.com

Daxor Corporation (DXR) Q3 2007 Earnings: EPS Surges 325% Above Estimates, Stock Declines Despite Beat - newsline.com

Daxor (DXR) plans June 23, 2026 vote on directors and auditor - Stock Titan

Daxor (DXR) Proxy filing Summary - Quartr

Daxor (DXR) Secures Patent for Innovative Blood Volume Monitorin - GuruFocus

Daxor Corporation Receives U.S. Patent for Breakthrough Remote Blood Volume Monitor - GlobeNewswire

Daxor Corporation (DXR) 재무 분석

매출

순이익

현금흐름

주당 순 이익

Daxor Corporation 주식 (DXR) 내부자 거래

DXR과 유사한 종목